Board Thread:Game Discussion/@comment-116.68.122.163-20180628145149/@comment-28169398-20180629171045

SM Racer wrote: Amrosa wrote: It is the balancing act of the artist and the accountant. What you are saying is true in the beginning of a venture, however once you open the door even a crack to investors, you pretty much lose the opportunity to make decisions that are not profit driven. You do NOT "pretty much lose the opportunity to make decisions that are not profit driven", but it is a balancing act. I don't want to go into my real life professional situation but suffice it to say that that particular balancing act is my life. Balancing acts are fine. We all balance stuff in many different aspects of our lives. Statements like "they don't really care about making racing games" are cynical and deny that there's even a balancing act. It's just a short step from there to statements like 'pharma companies try to keep people sick so they can sell more drugs' and other such utter BS. I worked in finance for over 15 years. Venture capitalists and I Bankers like good ideas, but are going to enforce revenue and profit targets over dream projects.

I am now working with people who are going through seed funding.

Look at the new content in the game.
 * Everything is a formula. Every car of a certain PR is 3 hour repair time.
 * Most of the new cars are easy to drive with a certain amount of upgrades and full upgrades make cars remarkably balanced and easy to handle.
 * Once you get a certain amount of experience even auralpod sucks
 * LTS no longer have long races, even for cars as spectacular a performer as the 2018 RSR.
 * Venom GT one Suzuka East in WTTT.
 * GP courses missing from Series with F1-pedigree cars or with only a single lap cup race.
 * Not making series that are obvious winners; P1 GTR v. FXX K v. C-X75 R3-Spec v. One:1 v. Regera for example
 * Only having a decent fame payout for races on Le Mans

And you bring up Pharma. It isn't that they try to keep people sick, it is that they make decisions not to develop drugs that are not going to be profitable. Antibiotics are a money losing proposition, and there are no pharmaceutical companies that are voluntarily researching the next generation of antibiotics to fight the superbugs.